DelistingOct 16, 2026, 04:11 PM
Callan JMB Inc. Faces Nasdaq Delisting Over Equity Deficiency
AI Summary
Callan JMB Inc. has received a determination from Nasdaq that it has failed to meet the minimum stockholders' equity requirement for continued listing. The company was previously notified of a deficiency and granted an extension until October 5, 2026. As capital raising initiatives were unsuccessful, Nasdaq has determined non-compliance. Trading suspension and delisting are set for October 21, 2026, unless an appeal is filed by October 19, 2026. The company has requested a hearing to appeal this determination and intends to demonstrate compliance.
Key Highlights
- Callan JMB Inc. received a deficiency letter from Nasdaq for failing to meet the Stockholders' Equity Requirement.
- The company was granted an extension until October 5, 2026, to regain compliance.
- On October 12, 2026, Nasdaq determined the company did not meet the extension terms.
- Trading suspension and delisting are scheduled for October 21, 2026, unless an appeal is requested by October 19, 2026.
- Callan JMB Inc. has requested a hearing before a Nasdaq Hearings Panel to appeal the determination.
Price Impact
More from CJMB